The bioavailability of drugs administered intravenously is what percentage?

Correct answer: 100 percent

Explanation

This is a fundamental concept in pharmacokinetics. Understanding that IV administration results in 100 percent bioavailability explains why IV doses are often much smaller than oral doses of the same drug and why their onset of action is typically faster.

Other questions

Question 1

In the index of Davis's Drug Guide for Nurses, what does the maple leaf icon next to an entry signify?

Question 2

What type of information is denoted by the double helix icon in the drug monographs?

Question 3

Within the drug monographs, what is the purpose of highlighting certain critical information in red?

Question 4

According to the guide, which of the following is an example of a 'high alert' medication?

Question 5

Which organization is credited with identifying the medications designated as 'high alert drugs' in the guide?

Question 6

How are brand names that have been discontinued indicated in the Drug Monographs section?

Question 7

In the 'Classification' section of a drug monograph, which type of classification is listed first?

Question 8

Why are Schedule I drugs not included in Davis's Drug Guide for Nurses?

Question 9

What has replaced the former Pregnancy Category letter system (A, B, C, D, X) in the drug monographs?

Question 10

In addition to FDA-approved uses, what other type of uses does the 'Indications' section include?

Question 11

What does the 'Pharmacokinetics' section of a drug monograph describe?

Question 12

According to the 'Distribution' subsection, information on protein binding is included for drugs that are more than what percent bound to plasma proteins?

Question 13

Which measurement is used to quantify renal function and guide dosage adjustments, with formulas for its estimation found in Appendix F?

Question 14

What information is provided in the 'Time/Action Profile' table within a drug monograph?

Question 15

In the 'Adverse Reactions and Side Effects' section, how are life-threatening adverse reactions or side effects formatted?

Question 16

What is the incidence rate for side effects that are underlined in the 'Adverse Reactions and Side Effects' section?

Question 17

According to the guide, what is the incidence range for adverse reactions that are listed but are neither capitalized nor underlined?

Question 18

Which nursing diagnosis, fundamental to all nurse-patient interactions involving medication, should be assumed to be applicable to all drugs?

Question 19

In the 'Implementation' subsection, what information does the 'PO' heading provide?

Question 20

Within the 'IV Administration' section, which critical information is highlighted with bold, red headings to make it easy to find?

Question 21

The 'Y-Site Compatibility/Incompatibility' section provides information for administering medications through which methods?

Question 22

From which two sources is the compatibility information in the guide compiled?

Question 23

What is the purpose of the 'Home Care Issues' heading within the 'Patient/Family Teaching' section?

Question 24

What does the 'Evaluation' section of a drug monograph provide?

Question 25

How many 'Safe Medication Use Articles' are listed as comprising the overview of medication safety issues?

Question 26

What does the presence of a 'REMS' label at the top of a drug monograph signify?

Question 27

The 'Special Dosing Considerations' article identifies specific patient populations who require careful dose adjustments. Which of the following examples are given?

Question 28

What is the primary purpose of the 'Classifications Profile' section?

Question 29

In a drug monograph for a high alert medication, where is the 'high alert tab' located?

Question 30

The pharmacologic classification of a drug is based on what characteristic?

Question 31

Which appendix is referenced for a description of the Schedule of Controlled Substances?

Question 33

What does the abbreviation 'Misc' stand for in the list of body system abbreviations for Adverse Reactions?

Question 34

What type of information has been added to the 'Availability' section to improve compliance and adherence in pediatric patients?

Question 35

The 'Toxicity and Overdose' subsection alerts the nurse to signs and symptoms of toxicity and also provides what other critical information?

Question 36

For which method of IV administration does the guide specify that a quick reference for dilution amounts in neonates and infants is contained in the new Medication Safety Tools section?

Question 37

The compatibility of diluted medications administered through a Y-site for continuous or intermittent infusion is usually limited to how many hours?

Question 38

The 16th edition focuses on safe medication administration by including more information about health care's most vulnerable patients. Which specific patient headings are mentioned as being found throughout the monographs?

Question 39

Which safe medication use article is described as explaining strategies developed by the pharmaceutical industry and required by the FDA to minimize adverse drug reactions from potentially dangerous drugs?

Question 40

Which section is described as providing tables and charts that nurses can use for quick reference to help avoid medication errors, including lists of drugs associated with falls in the elderly and confused drug names?

Question 41

What is the definition of a drug's half-life as provided in the guide?

Question 42

The 'Contraindications and Precautions' section lists situations where drug use should be avoided. What is the difference between an 'absolute' and a 'relative' contraindication?

Question 43

In the 'Route and Dosage' section, how are dosage units for penicillin G expressed?

Question 44

What information does the 'Lab Test Considerations' section provide to the nurse?

Question 45

The 'Implementation' subsection of the Nursing Implications provides guidelines for medication administration. If applicable, what information is included first in this subsection?

Question 46

What does the 'Additive Compatibility/Incompatibility' section identify?

Question 47

What is the purpose of the 'Solution Compatibility/Incompatibility' section?

Question 48

In the 'Patient/Family Teaching' section, what information is presented to the patient and family?

Question 49

Which safe medication use article teaches about 'high alert' medications, which have a greater potential to cause patient harm?

Question 50

According to the description of the 'IV Push' subsection, what details are provided for administering medications directly from a syringe?